Can Self-Sampling and care navigators beat cervical cancer in kenya?
NCT ID NCT07050745
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program called DADA-LINK to help more women in Kenya get screened for cervical cancer. The program includes HPV self-sampling kits, a care navigator to guide patients, and a phone app to track care. About 1,980 women aged 25-49 will take part, and researchers will see if the program increases screening and treatment rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HPV self-sampling kit, care navigation, mHealth platform
What this could lead to
If successful, this could show a practical way to increase cervical cancer screening and follow-up in low-resource settings, potentially saving lives through earlier detection.
What could go wrong
This is an implementation study, not a test of a new treatment. Results may not apply to other regions or populations. The study is relatively small and short-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kenyatta National Hospital
RECRUITINGNairobi, Kenya
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact